Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey

Citation
N. Salooja et al., Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey, LANCET, 358(9278), 2001, pp. 271-276
Citations number
28
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
LANCET
ISSN journal
01406736 → ACNP
Volume
358
Issue
9278
Year of publication
2001
Pages
271 - 276
Database
ISI
SICI code
0140-6736(20010728)358:9278<271:POAPBO>2.0.ZU;2-N
Abstract
Background Some patients treated by transplantation of haemopoietic stem ce lls (peripheral blood or bone marrow) become permanently infertile, but oth ers retain or recover fertility. We assessed the outcome of conception in w omen, and partners of men previously treated by autologous or allogeneic st em cell transplantation (SCT). Methods We sent questionnaires to 229 centres of the European Group for Blo od and Marrow Transplantation. We sought details about the original disease , transplant procedure, and outcome of conception for both male and female patients. Findings 199 centres gave information relating to 19 412 allogeneic and 17 950 autologous transplant patients. 232 (0.6%) patients conceived after SCT . Crude annual birth rate for 4-month survivors of SCT was lower than the n ational average for England and Wales at 1.7 per 1000 patients. 312 concept ions were reported in 113 patients (74 allograft) and partners of 119 patie nts (93 allograft). Most pregnancies were uncomplicated and resulted in 271 livebirths. 28 (42%) of 67 allograft recipients had caesarean section comp ared with 16% in the normal population (difference=26% [95% CI 15-38]), 12 (20%) of 59 had preterm delivery compared with a normal rate of 6% (14% [4- 24]), and 12 (23%) of 52 had low birthweight singleton offspring compared w ith a normal rate of 6% (17% [6-29]). Interpretation Pregnancy after SCT is likely to have a successful outcome. Pregnancies in allograft patients who have received total body irradiation should be treated as high risk for maternal and fetal complications.